Form 4: eGain Corp CFO Eric Smit Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
eGain Corp's CFO, Eric Smit, exercised stock options and sold 22,000 shares of common stock on September 4, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On September 4, 2024, Eric Smit, the Chief Financial Officer of eGain Corporation, executed a transaction involving the company's stock.
- Smit exercised an employee stock option to acquire 22,000 shares of common stock at an exercise price of $6.29 per share.
- Simultaneously, Smit sold 22,000 shares of common stock at a weighted average price of $6.5371, with individual sales prices ranging from $6.45 to $6.68.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 8, 2024.
- Following these transactions, Smit directly owns 130,648 shares of eGain Corp.
- This total includes 1,461 restricted stock units granted on November 10, 2023.
Sentiment
Score: 5
Explanation: Neutral sentiment. This is a standard disclosure of insider trading activity, with no clear positive or negative implications for the company's performance.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It's common for executives to have pre-arranged trading plans (Rule 10b5-1) to avoid accusations of trading on non-public information. The market will likely interpret this as a standard part of executive compensation and portfolio management.
Comparison to Industry Standards
- Executive stock option exercises and sales are common across publicly traded companies, particularly in the tech sector.
- Companies like Salesforce, Oracle, and Adobe also see regular Form 4 filings from their executives.
- The use of Rule 10b5-1 plans is a standard practice to ensure compliance with insider trading regulations.
- The size of the transaction (22,000 shares) is relatively small compared to the overall trading volume of EGAN, suggesting it's unlikely to have a significant impact on the stock price.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 09/11/2018 | Employee Stock Option Date Exercisable |
| 11/10/2023 | Grant date of 1,461 restricted stock units. |
| 03/08/2024 | Date of adoption of Rule 10b5-1 trading plan. |
| 09/04/2024 | Date of stock option exercise and stock sale. |
| 09/11/2024 | Employee Stock Option Expiration Date |
| 09/05/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.